Narinder Singh
Hoofd Techniek/Wetenschap/O&O bij ARCELLX, INC.
Actieve functies van Narinder Singh
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ARCELLX, INC. | Hoofd Techniek/Wetenschap/O&O | 01-10-2021 | - |
Loopbaan van Narinder Singh
Eerdere bekende functies van Narinder Singh
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| FORTE BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-08-2021 | 01-10-2021 |
| AIMMUNE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 06-07-2020 | 01-07-2021 |
| GENOCEA BIOSCIENCES, INC. | Corporate Officer/Principal | 01-03-2018 | 01-07-2020 |
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-07-2015 | 01-03-2018 |
Opleiding van Narinder Singh
| Indian Institute of Technology New Delhi | Graduate Degree |
| University of Houston | Graduate Degree |
| UCLA Anderson School of Management | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 8 |
| India | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Graduate Degree | 2 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| ARCELLX, INC. | Health Technology |
| FORTE BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
- Beurs
- Insiders
- Narinder Singh
- Ervaring
